Clinical Trial Update: A Study to Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept

View source ↗

Summary

This completed clinical trial update evaluates treatment patterns, outcomes, and healthcare resource utilization in patients with lower-risk myelodysplastic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Myelodysplastic Syndromes | Status: COMPLETED